CLINICAL PHARMACOLOGY & THERAPEUTICS
Scope & Guideline
Leading the way in pharmacology and therapeutics excellence.
Introduction
Aims and Scopes
- Pharmacokinetics and Pharmacodynamics:
Research articles often focus on the pharmacokinetic and pharmacodynamic modeling of drugs, including how various patient factors such as age, weight, and organ function influence drug behavior in the body. - Pharmacogenomics and Personalized Medicine:
The journal emphasizes the role of genetic factors in drug response, exploring how pharmacogenomic testing can guide personalized therapy and improve treatment outcomes. - Clinical Trials and Drug Development:
Publications frequently detail the design and outcomes of clinical trials, including innovative methodologies for trial design, ethical considerations, and regulatory implications. - Drug-Drug Interactions and Safety Assessments:
The impact of drug interactions on safety and efficacy is a critical area of focus, with studies evaluating the clinical significance of these interactions in diverse patient populations. - Real-World Evidence:
The journal promotes the use of real-world data to inform drug development and regulatory decision-making, providing insights into drug effectiveness and safety in everyday clinical practice. - Translational Research:
A consistent theme is the translation of preclinical findings into clinical applications, bridging the gap between laboratory research and patient care.
Trending and Emerging
- Artificial Intelligence and Machine Learning:
There is a growing trend towards the integration of AI and machine learning in drug development processes, predictive modeling, and personalized medicine, indicating a shift towards data-driven approaches in clinical pharmacology. - Real-World Data Utilization:
The use of real-world evidence is on the rise, with studies focusing on how real-world data can inform drug efficacy and safety, enhance clinical trial designs, and support regulatory decision-making. - Pharmacogenomics and Precision Dosing:
Research into pharmacogenomics is expanding, emphasizing the importance of genetic variability in drug metabolism and response, leading to more personalized and effective treatment regimens. - Innovations in Drug Delivery Systems:
Emerging studies are exploring novel drug delivery methods, including the use of biologics and advanced formulations that enhance therapeutic outcomes while minimizing side effects. - Focus on Rare Diseases:
An increasing number of publications are dedicated to the pharmacological management of rare diseases, reflecting a commitment to addressing unmet medical needs in this area. - Biologics and Biosimilars:
Research related to biologics, biosimilars, and their pharmacokinetic properties is trending, with an emphasis on safety, efficacy, and the implications for patient care.
Declining or Waning
- Traditional Pharmacology Models:
There is a noticeable decline in publications focused on traditional pharmacology models, as the field shifts towards more complex, systems-based approaches that incorporate pharmacogenomics and real-world evidence. - General Drug Class Studies:
Research examining broad classes of drugs without a specific focus on genetic or individual variabilities is becoming less common, with more emphasis now being placed on personalized medicine and targeted therapies. - Chronic Disease Management:
Topics related to general management strategies for chronic diseases are seeing reduced prominence, likely in favor of more innovative and tailored therapeutic approaches. - Preclinical Research:
There appears to be a waning interest in publishing preclinical studies that do not directly inform clinical applications, as the journal prioritizes translational research that connects laboratory findings to patient care.
Similar Journals
PHARMACOTHERAPY
Championing Innovation in Drug UtilizationPHARMACOTHERAPY, an esteemed journal published by WILEY, stands as a pivotal resource within the field of medical pharmacology. With its ISSN 0277-0008 and E-ISSN 1875-9114, this journal has been at the forefront of pharmacological research since its inception in 1981. Renowned for its rigorous peer-review process and impactful contributions, it currently holds a prestigious Q1 quartile ranking in the pharmacology category, underscoring its significance as a leading publication in the field. It ranks #40 out of 272 journals in Scopus, placing it in the top 15% percentile of its category. While not an open-access publication, PHARMACOTHERAPY remains committed to advancing knowledge and understanding in pharmacological sciences, making it an indispensable resource for researchers, healthcare professionals, and students dedicated to improving therapeutic outcomes and drug utilization. Based in the United States, at 111 River St, Hoboken, NJ, the journal is poised to continue its impact through to 2024 and beyond, welcoming contributions that further the discourse in pharmacotherapy.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Advancing the Frontiers of Drug Discovery and TherapeuticsThe JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.
BRITISH JOURNAL OF PHARMACOLOGY
Pioneering insights into drug mechanisms and therapeutic innovations.British Journal of Pharmacology is a premier, peer-reviewed journal published by Wiley, specializing in the dynamic field of pharmacology. With a robust impact factor, this journal ranks in the top quartile (Q1) for pharmacology according to the 2023 category rankings, emphasizing its significance and reputation among the global scientific community. As an essential resource for researchers, professionals, and students alike, the journal provides a platform for innovative research spanning foundational studies to clinical applications in pharmacology, toxicology, and pharmaceutics. Since its inception in 1966, the journal has consistently contributed to the advancement of pharmacological science, fostering a deeper understanding of drug action mechanisms and therapeutic advancements. Although primarily subscription-based, the British Journal of Pharmacology is committed to disseminating high-quality research that shapes the future of the field.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
Advancing cardiovascular health through innovative pharmacology.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is a leading peer-reviewed journal dedicated to the exploration and advancement of pharmacological therapies related to cardiovascular diseases. With its ISSN 0160-2446 and E-ISSN 1533-4023, this esteemed journal has been at the forefront of cardiovascular research since its inception in 1979, continuously offering insights until 2024. It holds a commendable position in the 2023 category quartiles, classified as Q2 in both Cardiology and Cardiovascular Medicine, as well as Medicine (miscellaneous) and Pharmacology, showcasing its significance within these fields. The journal presents a unique platform for researchers, health professionals, and students to disseminate their findings, fostering an environment of knowledge growth and collaboration in cardiovascular pharmacology. Readers can expect to find high-quality articles that contribute to the body of knowledge in cardiovascular therapies, ensuring they remain informed of the latest advancements and clinical practices. Discover more about this influential publication and its commitment to enhancing cardiovascular health.
ANTI-CANCER DRUGS
Innovating Strategies in Anti-Cancer ResearchANTI-CANCER DRUGS is a leading journal in the domain of cancer research and pharmacology, published by Lippincott Williams & Wilkins. With its inception dating back to 1990 and ongoing publication through 2024, this journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements and discoveries in cancer therapeutics. Although classified in the Q3 quartile across relevant categories such as Cancer Research and Oncology, its growing impact is evidenced by its competitive Scopus rankings, positioned within the 30th to 52nd percentiles across various disciplines. The journal remains committed to promoting innovative research that can translate into effective anti-cancer strategies, providing valuable insights into drug development and applications. While it does not currently offer open access, the journal continues to attract a sophisticated readership, making it an essential platform for disseminating significant findings in the ever-evolving field of oncology.
Journal of Pharmaceutical Health Care and Sciences
Exploring the nexus of pharmacy and healthcare excellence.The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.
Translational and Clinical Pharmacology
Unveiling Mechanisms, Transforming MedicineTranslational and Clinical Pharmacology, published by KSCPT, is an esteemed journal that serves as a vital source of knowledge in the field of pharmacology, particularly focusing on the translational aspects that bridge laboratory research and clinical applications. Established in 2014, this journal aims to disseminate high-quality research and reviews pertaining to drug development, therapeutics, and the underlying mechanisms of action in the medical realm. With an ISSN of 2289-0882 and an E-ISSN of 2383-5427, it holds a significant position with a Q3 ranking in the pharmacology category as of 2023, emphasizing its role in advancing scientific understanding within this crucial discipline. While it operates as a traditional subscription-based journal, its output remains accessible through various academic platforms, contributing to the global discourse in pharmacology. Researchers, professionals, and students will find value in its insightful articles and comprehensive studies, underscoring the journal’s commitment to enhancing pharmacological knowledge and practice.
CTS-Clinical and Translational Science
Fostering global collaboration in clinical and translational research.CTS-Clinical and Translational Science, published by WILEY, is a leading journal dedicated to advancing the fields of biochemistry, genetics, molecular biology, medicine, neuroscience, and pharmacology. With its Open Access policy since 2016, the journal ensures that groundbreaking research is readily available to a global audience, fostering collaboration and innovation. Based in the United Kingdom, CTS boasts a commendable Impact Factor that reflects its esteemed status, ranking in the Q1 category for various disciplines, including Pharmacology, Toxicology, and Pharmaceutics, and Biochemistry, Genetics and Molecular Biology. With its convergence years from 2008 to 2024, the journal remains at the forefront of scientific discovery, actively promoting novel research that bridges the gap between laboratory results and clinical application. Researchers, professionals, and students alike will find CTS an invaluable resource for the latest insights and advancements in clinical and translational science.
CLINICAL PHARMACOKINETICS
Decoding the Complexities of PharmacokineticsCLINICAL PHARMACOKINETICS, published by ADIS INT LTD, is a premier journal dedicated to the field of pharmacology, with a distinguished reputation since its inception in 1976. With an impressive impact factor and categorized in the Q1 quartile for both general pharmacology and medical pharmacology, this journal ranks #29 out of 272 and #53 out of 313 in its respective categories in Scopus, highlighting its high academic influence and the quality of research it publishes. CLINICAL PHARMACOKINETICS serves as a vital resource for researchers, professionals, and students interested in the latest advancements in drug metabolism, therapeutic efficacy, and clinical applications of pharmacokinetic studies. As it continues to evolve through 2024 and beyond, the journal remains committed to fostering a deeper understanding of pharmacotherapy and its implications in clinical practice. While it does not currently offer open access, the journal ensures that cutting-edge research is accessible through various academic platforms.
JOURNAL OF CLINICAL PHARMACOLOGY
Exploring the Frontiers of Pharmacological ResearchWelcome to the Journal of Clinical Pharmacology, an esteemed publication in the field of pharmacology and medical pharmacology, published by Wiley. Since its inception in 1973, this journal has been at the forefront of disseminating innovative research findings and comprehensive reviews that enhance our understanding of drug therapies and their clinical applications. With an impact factor that reflects its strong reputation and a Scopus ranking placing it in the 64th percentile among 272 journals in medical pharmacology, the journal stands as a critical resource for researchers, healthcare professionals, and students alike. Although currently not an Open Access journal, it provides invaluable insights into therapeutic drug use and safety, the pharmacokinetics of drugs, and the development of new therapeutic strategies. The journal's commitment to advancing the field through high-quality, peer-reviewed articles ensures it remains a vital asset in the continuously evolving landscape of clinical pharmacology.